332 related articles for article (PubMed ID: 9061094)
1. Morphine metabolites.
Christrup LL
Acta Anaesthesiol Scand; 1997 Jan; 41(1 Pt 2):116-22. PubMed ID: 9061094
[TBL] [Abstract][Full Text] [Related]
2. Relationships among morphine metabolism, pain and side effects during long-term treatment: an update.
Andersen G; Christrup L; Sjøgren P
J Pain Symptom Manage; 2003 Jan; 25(1):74-91. PubMed ID: 12565191
[TBL] [Abstract][Full Text] [Related]
3. Morphine and morphine metabolite concentrations in cerebrospinal fluid and plasma in cancer pain patients after slow-release oral morphine administration.
Wolff T; Samuelsson H; Hedner T
Pain; 1995 Aug; 62(2):147-154. PubMed ID: 8545139
[TBL] [Abstract][Full Text] [Related]
4. Concentrations of morphine and morphine metabolites in CSF and plasma during continuous subcutaneous morphine administration in cancer pain patients.
Wolff T; Samuelsson H; Hedner T
Pain; 1996 Dec; 68(2-3):209-16. PubMed ID: 9121807
[TBL] [Abstract][Full Text] [Related]
5. Sex-dependent influences of morphine and its metabolites on pain sensitivity in the rat.
Doyle HH; Murphy AZ
Physiol Behav; 2018 Apr; 187():32-41. PubMed ID: 29199028
[TBL] [Abstract][Full Text] [Related]
6. The effect of old age on the disposition and antinociceptive response of morphine and morphine-6 beta-glucuronide in the rat.
Van Crugten JT; Somogyi AA; Nation RL; Reynolds G
Pain; 1997 Jun; 71(2):199-205. PubMed ID: 9211481
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of morphine and its glucuronides following intravenous administration of morphine in patients undergoing continuous ambulatory peritoneal dialysis.
Pauli-Magnus C; Hofmann U; Mikus G; Kuhlmann U; Mettang T
Nephrol Dial Transplant; 1999 Apr; 14(4):903-9. PubMed ID: 10328468
[TBL] [Abstract][Full Text] [Related]
8. Randomized placebo-controlled trial of the activity of the morphine glucuronides.
Penson RT; Joel SP; Bakhshi K; Clark SJ; Langford RM; Slevin ML
Clin Pharmacol Ther; 2000 Dec; 68(6):667-76. PubMed ID: 11180027
[TBL] [Abstract][Full Text] [Related]
9. Morphine-6beta-glucuronide and morphine-3-glucuronide, opioid receptor agonists with different potencies.
Ulens C; Baker L; Ratka A; Waumans D; Tytgat J
Biochem Pharmacol; 2001 Nov; 62(9):1273-82. PubMed ID: 11705461
[TBL] [Abstract][Full Text] [Related]
10. Morphine-6-O-beta-D-glucuronide but not morphine-3-O-beta-D-glucuronide binds to mu-, delta- and kappa- specific opioid binding sites in cerebral membranes.
Löser SV; Meyer J; Freudenthaler S; Sattler M; Desel C; Meineke I; Gundert-Remy U
Naunyn Schmiedebergs Arch Pharmacol; 1996 Jul; 354(2):192-7. PubMed ID: 8857597
[TBL] [Abstract][Full Text] [Related]
11. Concentrations of morphine, morphine-6-glucuronide and morphine-3-glucuronide in serum and cerebrospinal fluid following morphine administration to patients with morphine-resistant pain.
Goucke RC; Hackett PL; Ilett KF
Pain; 1994 Feb; 56(2):145-149. PubMed ID: 8008404
[TBL] [Abstract][Full Text] [Related]
12. Morphine-3-glucuronide may functionally antagonize morphine-6-glucuronide induced antinociception and ventilatory depression in the rat.
Qian-Ling G; Hedner J; Björkman R; Hedner T
Pain; 1992 Feb; 48(2):249-255. PubMed ID: 1589243
[TBL] [Abstract][Full Text] [Related]
13. Plasma concentrations of morphine, morphine-6-glucuronide and morphine-3-glucuronide and their relationship with analgesia and side effects in patients with cancer-related pain.
Quigley C; Joel S; Patel N; Baksh A; Slevin M
Palliat Med; 2003 Mar; 17(2):185-90. PubMed ID: 12701850
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of morphine and its glucuronidated metabolites in burn injuries.
Perreault S; Choinière M; du Souich PB; Bellavance F; Beauregard G
Ann Pharmacother; 2001 Dec; 35(12):1588-92. PubMed ID: 11793627
[TBL] [Abstract][Full Text] [Related]
15. Effects of morphine glucuronides on the function of opioid receptors in human SK-N-SH cells.
Baker L; Dye A; Ratka A
Neurosci Lett; 2000 Mar; 281(1):1-4. PubMed ID: 10686401
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the disposition of hepatically-generated morphine-3-glucuronide and morphine-6-glucuronide in isolated perfused liver from the guinea pig.
Milne RW; Jensen RH; Larsen C; Evans AM; Nation RL
Pharm Res; 1997 Aug; 14(8):1014-8. PubMed ID: 9279882
[TBL] [Abstract][Full Text] [Related]
17. Modulation of metabolic effects of morphine-6-glucuronide by morphine-3-glucuronide.
Hashiguchi Y; Molina PE; Abumrad NN
Brain Res Bull; 1995; 38(4):325-9. PubMed ID: 8535854
[TBL] [Abstract][Full Text] [Related]
18. CSF and plasma concentrations of morphine and morphine glucuronides in cancer patients receiving epidural morphine.
Samuelsson H; Hedner T; Venn R; Michalkiewicz A
Pain; 1993 Feb; 52(2):179-185. PubMed ID: 8455965
[TBL] [Abstract][Full Text] [Related]
19. The influence of the route of administration: a comparative study at steady state of oral sustained release morphine and morphine sulfate suppositories.
Du X; Skopp G; Aderjan R
Ther Drug Monit; 1999 Apr; 21(2):208-14. PubMed ID: 10217341
[TBL] [Abstract][Full Text] [Related]
20. Influence of ranitidine on the morphine-3-glucuronide to morphine-6-glucuronide ratio after oral administration of morphine in humans.
Aasmundstad TA; Størset P
Hum Exp Toxicol; 1998 Jun; 17(6):347-52. PubMed ID: 9688360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
